GO
Loading...

It's Time for the Lightning Round!


Canon : “Apple is so much better than Canon,” Cramer said. “Keep looking at Canon but buy more Apple.”

W.W. Grainger : Cramer thinks GWW could be one of those $80 to $120 stocks, so you should stay long.

Varian Medical Systems : “Integrated cancer care systems are where the action is,” Cramer said, which is why he’s bullish on VAR as well as Hologix . And with VAR off 12 points from its high, Cramer thinks it’s going higher.

Moody's : “Moody’s is tough money,” Cramer said. There are shorts all over it and he doesn’t have time for that.

AT&T : “I think they were visionaries to bet with the iPhone,” Cramer said. “It’s a classic case of a well-run company with a good dividend that’s doing well.”

Whirlpool : Appliance sales seem to be down everywhere, yet Whirlpool goes up. At $100, Cramer would buy it and at $120, he’d sell it. Right now it’s in the middle of the range which makes it “too difficult.”

Bank of America : Cramer said there’s one point of downside and four points of upside – “that’s a thing of beauty.”

Tyco : Ring the register and take your profits here, Cramer said.

Amgen : In biotech, Cramer’s picks are Celgene , Nastech , Genentech and then - and only then - Amgen.



Jim's charitable trust owns NYSE Euronext, Goldman Sachs, Sears Holdings and Hologix

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book